- Home
- LUCY vs NURO Comparison
LUCY vs NURO Comparison
Compare LUCY & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCY
- NURO
- Stock Information
- Founded
- LUCY 2017
- NURO 1996
- Country
- LUCY United States
- NURO United States
- Employees
- LUCY N/A
- NURO N/A
- Industry
- LUCY Ophthalmic Goods
- NURO Medical/Dental Instruments
- Sector
- LUCY Health Care
- NURO Health Care
- Exchange
- LUCY Nasdaq
- NURO Nasdaq
- Market Cap
- LUCY 18.5M
- NURO 8.2M
- IPO Year
- LUCY 2022
- NURO N/A
- Fundamental
- Price
- LUCY $6.90
- NURO $4.42
- Analyst Decision
- LUCY Strong Buy
- NURO
- Analyst Count
- LUCY 1
- NURO 0
- Target Price
- LUCY $20.00
- NURO N/A
- AVG Volume (30 Days)
- LUCY 104.1K
- NURO 14.4K
- Earning Date
- LUCY 11-12-2024
- NURO 11-01-2024
- Dividend Yield
- LUCY N/A
- NURO N/A
- EPS Growth
- LUCY N/A
- NURO N/A
- EPS
- LUCY N/A
- NURO N/A
- Revenue
- LUCY $1,529,782.00
- NURO $4,383,614.00
- Revenue This Year
- LUCY $245.17
- NURO N/A
- Revenue Next Year
- LUCY $258.97
- NURO N/A
- P/E Ratio
- LUCY N/A
- NURO N/A
- Revenue Growth
- LUCY 186.54
- NURO N/A
- 52 Week Low
- LUCY $3.26
- NURO $2.66
- 52 Week High
- LUCY $27.20
- NURO $5.60
- Technical
- Relative Strength Index (RSI)
- LUCY 44.95
- NURO 65.06
- Support Level
- LUCY $6.33
- NURO $3.96
- Resistance Level
- LUCY $6.89
- NURO $4.69
- Average True Range (ATR)
- LUCY 0.59
- NURO 0.22
- MACD
- LUCY -0.27
- NURO 0.04
- Stochastic Oscillator
- LUCY 14.46
- NURO 82.35
About LUCY Innovative Eyewear Inc.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products Lucyd Lyte glasses enable the wearer to listen to music, take and make calls, and use voice assistants to perform many common smartphone tasks hands free.
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.